Marshall Wace’s Abeona Therapeutics ABEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$969K Buy
+216,305
New +$1.08M ﹤0.01% 2148
2025
Q4
Sell
-11,800
Closed -$62.3K 2901
2025
Q3
$62.3K Sell
11,800
-73,324
-86% -$465K ﹤0.01% 2711
2025
Q2
$484K Sell
85,124
-247,276
-74% -$1.41M ﹤0.01% 2160
2025
Q1
$1.58M Buy
332,400
+281,072
+548% +$1.53M ﹤0.01% 1571
2024
Q4
$286K Sell
51,328
-32,846
-39% -$202K ﹤0.01% 2246
2024
Q3
$532K Buy
+84,174
New +$439K ﹤0.01% 1903
2024
Q2
Sell
-128,903
Closed -$935K 2486
2024
Q1
$935K Buy
128,903
+81,047
+169% +$514K ﹤0.01% 1685
2023
Q4
$240K Buy
+47,856
New +$211K ﹤0.01% 1932
2019
Q3
Sell
-530
Closed -$63K 1640
2019
Q2
$63K Buy
530
+167
+46% +$28K ﹤0.01% 1285
2019
Q1
$67K Sell
363
-4,155
-92% -$743K ﹤0.01% 1495
2018
Q4
$806K Sell
4,518
-7,428
-62% -$1.62M 0.01% 970
2018
Q3
$3.82M Buy
+11,946
New +$4.24M 0.03% 524

Other funds holding ABEO